| Literature DB >> 33404815 |
Vesile Yildiz Kabak1, Songul Atasavun Uysal2, Tulin Duger2.
Abstract
PURPOSE: The primary aim was to assess supportive care needs, compliance with home exercise program, quality of life level (QOL), and anxiety level during the COVID-19 pandemic in individuals treated with hematopoietic stem cell transplantation (HSCT). The secondary aim was to investigate demographic and medical factors associated with the recorded outcomes.Entities:
Keywords: COVID-19; Hematopoietic stem cell transplantation; Quality of life; Supportive care
Mesh:
Year: 2021 PMID: 33404815 PMCID: PMC7786319 DOI: 10.1007/s00520-020-05965-1
Source DB: PubMed Journal: Support Care Cancer ISSN: 0941-4355 Impact factor: 3.359
Demographic and medical characteristic of participants (n = 101)
| Outcomes | Mean ± SD (min-max) |
|---|---|
| Age, years | 50.83 ± 12.04 (20–70) |
| BMI, kg/m2 | 27.07 ± 4.63 (16.41–45.78) |
| Time since diagnosis, month | 31.67 ± 16.19 (9–84) |
| Time since HSCT, month | 17.02 ± 10.53 (1–48) |
| Gender, | |
| Male | 63 (62.4) |
| Female | 38 (37.6) |
| Diagnosis, | |
| MM | 36 (35.6) |
| Lymphoma | 36 (35.6) |
| Leukemia | 26 (25.7) |
| MDS | 3 (2.6) |
| ECOG performance status | |
| 0: Active | 18 (17.8) |
| 1: Limited vigorous physical activity | 59 (58.4) |
| 2: Symptomatic, independent in ADL | 22 (21.8) |
| 3: Limited ADL | 2 (2) |
| Marital status, | |
| Married | 89 (88.1) |
| Single | 12 (11.8) |
| Education level, | |
| Illiterate | 5 (5) |
| Elementary school | 35 (34.7) |
| Secondary school | 9 (8.9) |
| High school | 24 (23.8) |
| Graduate | 27 (26.7) |
| Postgraduate | 1 (1) |
| Comorbidity, | |
| Yes | 21 (20.8) |
| No | 80 (79.2) |
| Type of comorbidity, | |
| Cardiopulmonary disease | 10 (9.9) |
| Chronic kidney disease | 7 (6.9) |
| Migraine | 2 (2) |
| Rheumatoid arthritis | 2 (2) |
| Type of HSCT, | |
| Autologous | 71 (70.3) |
| Allogeneic | 30 (29.7) |
| Preparation regiment for HSCT, | |
| Myeloablative | 94 (93.0) |
| Reduced intensity | 7 (6.9) |
| Complication after HSCT, | |
| Yes | 12 (11.8) |
| No | 89 (88.1) |
| Type of complications, | |
| Veno-occlusive disease | 8 (7.9) |
| Cataract | 3 (2.6) |
| Asthma | 1 (1) |
| Current occupational status | |
| Yes | 14 (13.9) |
| No | 87 (86.1) |
BMI body mass index, HSCT hematopoietic stem cell transplantation, MM multiple myeloma, MDS myelodysplastic syndrome, ECOG the Eastern Cooperative Oncology Group Performance Score, ADL activities of daily living
Supportive care needs, compliance with the exercise program, quality of life level, and anxiety level of the participants
| Outcomes | Mean ± SD (min-max) | Female ( | Male ( | |
|---|---|---|---|---|
| SCNS-SF29 total score | 50.11 ± 14.30 (29–70) | 52.63 ± 14.18 | 48.60 ± 14.28 | 0.122 |
| ADLN | 10.33 ± 5.27 (5–19) | 11.07 ± 4.96 | 9.88 ± 5.44 | 0.197 |
| PN | 14.72 ± 4.63 (8–22) | 16.13 ± 4.38 | 13.87 ± 4.60 | 0.027* |
| HSCIN | 21.56 ± 6.32 (12–30) | 21.55 ± 6.36 | 21.57 ± 6.34 | 0.722 |
| SN | 3.49 ± 1.13 (3–9) | 3.86 ± 1.49 | 3.26 ± 0.78 | 0.610 |
| EORTC QLQ-C30, score | ||||
| General health | 78.54 ± 16.00 (33.33–100) | 76.31 ± 15.07 | 79.89 ± 16.50 | 0.164 |
| Functionality | 91.88 ± 10.82 (22.22–100) | 88.18 ± 13.86 | 94.11 ± 7.80 | 0.003* |
| Symptom | 7.23 ± 9.01 (0–51.28) | 9.85 ± 11.06 | 5.65 ± 7.16 | 0.039* |
| STAI-I, score | 37.00 ± 3.77 (31–45) | 36.39 ± 3.45 | 37.38 ± 3.93 | 0.384 |
| Anxiety regarding COVID-19 (0–10) | 4.13 ± 1.73 | 4.31 ± 1.84 | 4.03 ± 1.66 | 0.273 |
| Compliance with home EX (yes/no), | 8 (13.3)/52 (86.6) | 5 (14.2)/30 (85.7) | 3 (12)/22 (88) | 0.557 |
| Compliance with walking program (0–100%)** | 29.14 ± 16.30 | 27.03 ± 17.27 | 30.46 ± 15.72 | 0.328 |
Quality of Life Questionnaire-Cancer30, STAI-I State-Trait Anxiety Index-I, EX exercise program, Mann Whitney U test, *p ˂ 0.05. SCNS-SF29 Supportive Care Needs Survey-Short Form 29TR, ADLN activities of daily life need, PN psychological need, HSCIN healthcare service and informing need, SN sexuality need, EORTC QLQ-C30 European Cancer Research and Treatment Organization. **Totally 60 patients prescribed with home exercise program
Fig. 1The most reported unmet supportive care needs in patients treated with HSCT during the COVID-19 pandemic
Significant associated factors with supportive care needs, quality of life, and compliance with the exercise program during the COVID-19 pandemic
| Outcomes | |
|---|---|
| SCNS-SF29 & ECOG | 0.343** |
| SCNS-SF29 & time since HSCT | − 0.265* |
| SCNS-SF29 & functionality | − 0.420** |
| SCNS-SF29 & symptom | 0.483** |
| SCNS-SF29 & general health | − 0.614** |
| STAI-I & SCNS-SF29 | 0.331* |
| STAI-I & COVID-19-related anxiety | 0.659** |
| STAI-I & general health | − 0.350* |
| Compliance with EX & age | − 0.238* |
| Compliance with EX & ECOG | − 0.395* |
| Compliance with EX & functionality | 0.395* |
| Compliance with EX & general health | 0.293* |
| Compliance with EX & symptom | − 0.325* |
SCNS-SF29 Supportive Care Needs Survey-Short Form 29TR, STAI-I State-Trait Anxiety Index-I, ECOG Eastern Cooperative Oncology Group Performance Score, HSCT hematopoietic stem cell transplantation, EX exercise program. Spearman correlation coefficient test, *p ˂ 0.05, **p ˂ 0.001